Trials / Completed
CompletedNCT01391676
Imaging of Trabeculectomy Blebs Using the Spectral Domain Optical Coherence Tomography
Imaging of Blebs After Trabeculectomy With Mitomycin C 0,02% Using the Spectral Domain Optical Coherence Tomography
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Technische Universität Dresden · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is imaging of trabeculectomy blebs regarding structure and function with the spectral domain optical coherence tomography.
Detailed description
After a trabeculectomy with mitomycin C 0,02% for 3 minutes, the blebs are controlled by a glaucoma specialist on day 1, week 1,2,3,4, month 3 and 6 after surgery. The glaucoma specialist will evaluate the bleb appearance according to a standardized protocol. At the same time points the bleb will be imaged with the spectral domain optical coherence tomography, to monitor bleb changes objectively. The investigators hope to see signs of bleb incapsulation and scarring earlier and then treat the patient accordingly.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | trabeculectomy | postoperative imaging of trabeculectomy blebs with the spectral domain optical coherence tomography |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2011-07-12
- Last updated
- 2013-09-10
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01391676. Inclusion in this directory is not an endorsement.